202 related articles for article (PubMed ID: 11289162)
81. Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody.
Yoshinaga H; Matsuhashi S; Fujiyama C; Masaki Z
Pathol Int; 1999 Dec; 49(12):1067-77. PubMed ID: 10632927
[TBL] [Abstract][Full Text] [Related]
82. Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female ACI rats induced by estrogen.
Weroha SJ; Lingle WL; Hong Y; Li SA; Li JJ
Horm Cancer; 2010 Feb; 1(1):34-43. PubMed ID: 21761349
[TBL] [Abstract][Full Text] [Related]
83. Redundant cyclin overexpression and gene amplification in breast cancer cells.
Keyomarsi K; Pardee AB
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1112-6. PubMed ID: 8430082
[TBL] [Abstract][Full Text] [Related]
84. Epac1, PDE4, and PKC protein expression and their association with AKAP95, Cx43, and cyclinD2/E1 in breast cancer tissues.
Huang P; Sun Q; Zhuang W; Peng K; Wang D; Yao Y; Guo D; Zhang L; Shen C; Sun M; Tang C; Teng B; Zhang Y
Thorac Cancer; 2017 Sep; 8(5):495-500. PubMed ID: 28755423
[TBL] [Abstract][Full Text] [Related]
85. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR.
Evron E; Dooley WC; Umbricht CB; Rosenthal D; Sacchi N; Gabrielson E; Soito AB; Hung DT; Ljung B; Davidson NE; Sukumar S
Lancet; 2001 Apr; 357(9265):1335-6. PubMed ID: 11343741
[TBL] [Abstract][Full Text] [Related]
86. The PU.1 transcription factor induces cyclin D2 expression in U937 cells.
Vicari L; Eramo A; Manzella L; Malaguarnera L; Iannolo G; Gulisano M; De Maria R; Messina A; Vigneri P
Leukemia; 2006 Dec; 20(12):2208-10. PubMed ID: 17051239
[No Abstract] [Full Text] [Related]
87. Expression of calcium-binding protein S100A2 in breast lesions.
Liu D; Rudland PS; Sibson DR; Platt-Higgins A; Barraclough R
Br J Cancer; 2000 Dec; 83(11):1473-9. PubMed ID: 11076656
[TBL] [Abstract][Full Text] [Related]
88. BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers.
Hirata Y; Ogasawara N; Sasaki M; Mizushima T; Shimura T; Mizoshita T; Mori Y; Kubota E; Wada T; Tanida S; Kataoka H; Kamiya T; Higashiyama S; Joh T
Br J Cancer; 2009 Apr; 100(8):1320-9. PubMed ID: 19337254
[TBL] [Abstract][Full Text] [Related]
89. Detection of cyclin messenger RNAs by nonradioactive ribonuclease protection assay: a comparison of four detection methods.
Nass SJ; Dickson RB
Biotechniques; 1995 Nov; 19(5):772-6, 778. PubMed ID: 8588915
[TBL] [Abstract][Full Text] [Related]
90. Overexpression of the receptor tyrosine kinase Tie-1 intracellular domain in breast cancer.
Yang XH; Hand RA; Livasy CA; Cance WG; Craven RJ
Tumour Biol; 2003; 24(2):61-9. PubMed ID: 12853700
[TBL] [Abstract][Full Text] [Related]
91. Expression of pp32 gene family members in breast cancer.
Kadkol SS; El Naga GA; Brody JR; Bai J; Gusev Y; Dooley WC; Pasternack GR
Breast Cancer Res Treat; 2001 Jul; 68(1):65-73. PubMed ID: 11678310
[TBL] [Abstract][Full Text] [Related]
92. Refining the origins of breast cancer.
Norton L; Rosen PP; Rosen N
Nat Med; 1995 Dec; 1(12):1250-1. PubMed ID: 7489402
[No Abstract] [Full Text] [Related]
93. The expression level of small non-coding RNAs derived from the first exon of protein-coding genes is predictive of cancer status.
Zovoilis A; Mungall AJ; Moore R; Varhol R; Chu A; Wong T; Marra M; Jones SJ
EMBO Rep; 2014 Apr; 15(4):402-10. PubMed ID: 24534129
[TBL] [Abstract][Full Text] [Related]
94. Expression of LINE-1 retrotransposons in human breast cancer.
Bratthauer GL; Cardiff RD; Fanning TG
Cancer; 1994 May; 73(9):2333-6. PubMed ID: 8168038
[TBL] [Abstract][Full Text] [Related]
95. Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.
Albulescu R
Biomark Med; 2013 Apr; 7(2):203. PubMed ID: 23667945
[No Abstract] [Full Text] [Related]
96. Loss of expression of cyclin d2 by aberrant DNA methylation: a potential biomarker in vietnamese breast cancer patients.
Truong PK; Lao TD; Doan TP; Le TA
Asian Pac J Cancer Prev; 2015; 16(6):2209-13. PubMed ID: 25824739
[TBL] [Abstract][Full Text] [Related]
97. Single-cell and bulk RNA sequencing analysis of B cell marker genes in TNBC TME landscape and immunotherapy.
Zhao F; Zhao C; Xu T; Lan Y; Lin H; Wu X; Li X
Front Immunol; 2023; 14():1245514. PubMed ID: 38111587
[TBL] [Abstract][Full Text] [Related]
98. Differences and Similarities between Colorectal Cancer Cells and Colorectal Cancer Stem Cells: Molecular Insights and Implications.
Erisik D; Ozdil B; Acikgoz E; Asker Abdikan CS; Yesin TK; Aktug H
ACS Omega; 2023 Aug; 8(33):30145-30157. PubMed ID: 37636966
[TBL] [Abstract][Full Text] [Related]
99. Abrogating Metastatic Properties of Triple-Negative Breast Cancer Cells by EGFR and PI3K Dual Inhibitors.
Garcia AR; Mendes A; Custódia C; Faria CC; Barata JT; Malhó R; Figueira I; Brito MA
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568789
[TBL] [Abstract][Full Text] [Related]
100. D-Type Cyclins in Development and Disease.
Saleban M; Harris EL; Poulter JA
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
